W Dempke

Summary

Affiliation: Martin Luther University
Country: Germany

Publications

  1. ncbi request reprint Cisplatin resistance and oncogenes--a review
    W Dempke
    Department of Internal Medicine, Martin Luther University, Halle Saale, Germany
    Anticancer Drugs 11:225-36. 2000
  2. ncbi request reprint [Hemorrhagic diathesis as initial symptom of stomach carcinoma]
    W Dempke
    Klinik für Innere Medizin IV Hämatologie und Onkologie, Martin Luther Universitat Halle Wittenberg, Halle Saale, Bundesrepublik Deutschland
    Wien Klin Wochenschr 112:1053-8. 2000
  3. ncbi request reprint Cyclooxygenase-2: a novel target for cancer chemotherapy?
    W Dempke
    Department of Hematology and Oncology, Martin Luther University Halle Wittenberg, Halle Saale, Germany
    J Cancer Res Clin Oncol 127:411-7. 2001
  4. ncbi request reprint [Possible new indications for erythropoietin therapy]
    W Dempke
    Klinik für Innere Medizin IV Hämatologie und Onkologie, Martin Luther Universitat Halle Wittenberg
    Med Klin (Munich) 96:467-74. 2001
  5. ncbi request reprint Human hematopoietic growth factors: old lessons and new perspectives
    W Dempke
    Martin Luther University, Department of Hematology and Oncology, Ernst Grube Str 40, 06120 Halle Saale, Germany
    Anticancer Res 20:5155-64. 2000

Collaborators

Detail Information

Publications5

  1. ncbi request reprint Cisplatin resistance and oncogenes--a review
    W Dempke
    Department of Internal Medicine, Martin Luther University, Halle Saale, Germany
    Anticancer Drugs 11:225-36. 2000
    ....
  2. ncbi request reprint [Hemorrhagic diathesis as initial symptom of stomach carcinoma]
    W Dempke
    Klinik für Innere Medizin IV Hämatologie und Onkologie, Martin Luther Universitat Halle Wittenberg, Halle Saale, Bundesrepublik Deutschland
    Wien Klin Wochenschr 112:1053-8. 2000
    ..Microangiopathic hemolytic anemia (MAHA) and disseminated intravasal coagulation (DIC) as initial paraneoplastic symptoms of a solid tumor present a rare clinical situation...
  3. ncbi request reprint Cyclooxygenase-2: a novel target for cancer chemotherapy?
    W Dempke
    Department of Hematology and Oncology, Martin Luther University Halle Wittenberg, Halle Saale, Germany
    J Cancer Res Clin Oncol 127:411-7. 2001
    ..This may lead to new perspectives that by controlling the cancer phenotype, rather than attempting to eradicate all affected cells, may provide significant benefits to the cancer patient...
  4. ncbi request reprint [Possible new indications for erythropoietin therapy]
    W Dempke
    Klinik für Innere Medizin IV Hämatologie und Onkologie, Martin Luther Universitat Halle Wittenberg
    Med Klin (Munich) 96:467-74. 2001
    ..Currently, new EPO derivatives, synthetic fusion proteins and gene therapeutic studies are under clinical investigation suggesting that the EPO-induced effects may be increased significantly by these agents in the future...
  5. ncbi request reprint Human hematopoietic growth factors: old lessons and new perspectives
    W Dempke
    Martin Luther University, Department of Hematology and Oncology, Ernst Grube Str 40, 06120 Halle Saale, Germany
    Anticancer Res 20:5155-64. 2000
    ..Preliminary results suggest that these compounds may have a major impact on the management of myeloablative chemotherapy because of their ability to enhance platelet recovery in addition to their neutrophil restorative activity...